WebNovellus Biopharma AG est située à Bahnhofstrasse 9, 6340 Baar, Switzerland, Baar (Zoug), Canton de Zoug. Q2. Existe-t-il un contact principal pour Novellus Biopharma AG? David Munoz est le contact principal chez Novellus Biopharma AG. Vous pouvez contacter David Munoz à l'adresse e-mail [email protected]. Web31 jan. 2013 · Headquartered in Switzerland, Novellus Biopharma AG strives to be the first Pan-Latin American provider of innovative and high value-added treatments for orphan …
Brooklyn ImmunoTherapeutics Completes Acquisition of
Web16 jun. 2024 · Public Company Edition: Direct Biologics, YishengBio and Estrella Biopharma will go public by merging with special purpose acquisition corporations. Also, Vir lands a government contract worth up to $1bn, Idorsia raises CHF164m ($167.4m) in a real estate deal and Adamis reviews alternatives. Web14 jun. 2024 · NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics LLC (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases, today … industrial bank association
www.sec.gov
Web• Dyax Corp., of Burlington, Mass., and Novellus Biopharma AG, of Bogota, Colombia, inked a partnership for the development and commercialization of hereditary angioedema drug Kalbitor (ecallantide) in select regions in Latin America, including Argentina, Brazil, Chile, Colombia, Mexico and Venezuela. WebNovellus Biopharma is a Swiss biopharma focused on Latin American geographies for Orphan Diseases. It works on the development, registration, and commercialization of … WebPOINT Biopharma. Jan 2024 - Present4 months. Indianapolis, Indiana, United States. At POINT! in Indianapolis we are focused on building the best world class radio pharmaceutical manufacturing. log driver\\u0027s waltz sheet music